Manojkumar Bupathi
Impact in
Papers in
- Co-authors
- Petros Grivas (13 shared papers)Yohann Loriot (13 shared papers)Daniel P. Petrylak (13 shared papers)Cora N. Sternberg (13 shared papers)Scott T. Tagawa (13 shared papers)Aude Fléchon (11 shared papers)Damien Pouessel (11 shared papers)Philippe Barthélémy (11 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (5 papers)Molecular Oncology (1 paper)Investigational New Drugs (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Manojkumar Bupathi
39 papers receiving 780 citations
Manojkumar Bupathi's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 443
- Surgery 397
- Cancer Research 82
- Pulmonary and Respiratory Medicine 170
- Hepatology 38
Countries citing papers authored by Manojkumar Bupathi
This map shows the geographic impact of Manojkumar Bupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manojkumar Bupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manojkumar Bupathi more than expected).
Fields of papers citing papers by Manojkumar Bupathi
This network shows the impact of papers produced by Manojkumar Bupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manojkumar Bupathi. The network helps show where Manojkumar Bupathi may publish in the future.
Co-authors
The 25 scholars most cited alongside Manojkumar Bupathi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors Hit paper breakdown → | 2021 | 351 |
| 2 | 2015 | 58 | |
| 3 | 2016 | 46 | |
| 4 | 2024 | 37 | |
| 5 | 2024 | 33 | |
| 6 | 2022 | 28 | |
| 7 | 2019 | 28 | |
| 8 | 2014 | 27 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2016 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2017 | 9 | |
| 19 | 2017 | 8 | |
| 20 | 2015 | 7 |
About Manojkumar Bupathi
Manojkumar Bupathi is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 44 papers that have together received 791 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (8 papers), Multiple and Secondary Primary Cancers (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Renal cell carcinoma treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (443 citations), Surgery (397 citations), Cancer Research (82 citations), Pulmonary and Respiratory Medicine (170 citations) and Hepatology (38 citations). Manojkumar Bupathi has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Petros Grivas, Yohann Loriot, Daniel P. Petrylak, Cora N. Sternberg, Scott T. Tagawa, Aude Fléchon, Damien Pouessel, Philippe Barthélémy, Neeraj Agarwal and Rohit Jain. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Molecular Oncology, Investigational New Drugs and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.